Shareholders

Shareholders in InDex Pharmaceuticals Holding AB as of December 31, 2018.

Shareholder Number of Shares Ownership, % Votes, %
SEB Venture Capital 14,657,241 21.3% 21.3%
Stiftelsen Industrifonden 12,900,272 18.8% 18.8%
NeoMed/N5 6,907,913 10.0% 10.0%
Staffan Rasjö 3,124,718 4.5% 4.5%
Linc AB 2,908,298 4.2% 4.2%
SEB Stiftelsen 1,785,714 2.6% 2.6%
SEB Life International 1,454,150 2.1% 2.1%
Skandinaviska Enskilda Banken S.A. 1,454,150 2.1% 2.1%
Avanza Pension 1,446,434 2.1% 2.1%
Ponderus Securities AB 1,348,996 2.0% 2.0%
Other 20,793,389 30.3% 30.3%
Total 68,781,275 100,0% 100,0%